# LDV Blog

DANNCE.AI is bringing to market a novel phenotyping platform to digitize the clinical assessments used by clinicians and drug developers to quantify movement. We led their $2.6M pre-seed round along with co-investors Glasswing Ventures, The Leo Lion Company, Duke Capital Partners, and Merck Digital Sciences Studio.

[Read More](/content/blog/ai-in-neuroscience-partnering-with-dannceai-to-increase-drug-efficacy-improve-the-lives-of-people-with-movement-disorders/index.html)

In 2019, we had the pleasure of hosting a fireside chat between Thomas Reardon, a computational neuroscientist, co-founder and CEO of CTRL-labs, and Evan Nisselson, Founder and General Partner at LDV Capital.

Four months later in September 2019, CTRL-Labs was acquired by Facebook for approximately $1 billion, reported VentureBeat. He and his team are now integrated into Facebook's AR/VR research group.

[Read More](/content/blog/2020/9/28/reimagining-the-relationship-between-humans-amp-machines-with-neural-interface-technology/index.html)